AAAAAA

   
Results: 1-25 | 26-50 | 51-59
Results: 1-25/59

Authors: POTTER WZ
Citation: Wz. Potter, IN-MEMORIAM - MARKKU I. LINNOILA, MD, PHD, Journal of clinical psychopharmacology, 18(5), 1998, pp. 362-363

Authors: KAUR D CRUESS DF POTTER WZ
Citation: D. Kaur et al., EFFECT OF IL-1-ALPHA ON THE RELEASE OF NOREPINEPHRINE IN RAT HYPOTHALAMUS, Journal of neuroimmunology, 90(2), 1998, pp. 122-127

Authors: POTTER WZ
Citation: Wz. Potter, BIPOLAR DEPRESSION - SPECIFIC TREATMENTS, The Journal of clinical psychiatry, 59, 1998, pp. 30-36

Authors: POTTER WZ
Citation: Wz. Potter, EARLY CLINICAL DEVELOPMENT OF PSYCHOACTIVE-DRUGS - PROS AND CONS OF ACADEMIC COLLABORATIONS, Biological psychiatry, 43, 1998, pp. 274-274

Authors: LIGHTFOOT JD HERRERA JM LANDIN R DEBROTA DJ OFFEN W DEMITRACK MA POTTER WZ
Citation: Jd. Lightfoot et al., IMPLICATIONS OF A SIGNIFICANT TREATMENT BY COUNTRY INTERACTION, Biological psychiatry, 43, 1998, pp. 324-324

Authors: RUDORFER MV POTTER WZ
Citation: Mv. Rudorfer et Wz. Potter, THE ROLE OF METABOLITES OF ANTIDEPRESSANTS IN THE TREATMENT OF DEPRESSION, CNS DRUGS, 7(4), 1997, pp. 273-312

Authors: SCHMIDT ME MATOCHIK JA GOLDSTEIN DS SCHOUTEN JL ZAMETKIN AJ POTTER WZ
Citation: Me. Schmidt et al., GENDER DIFFERENCES IN BRAIN METABOLIC AND PLASMA-CATECHOLAMINE RESPONSES TO ALPHA(2)-ADRENOCEPTOR BLOCKADE, Neuropsychopharmacology, 16(4), 1997, pp. 298-310

Authors: CHEN G YAN PX HAWVER DB POTTER WZ MANJI HK
Citation: G. Chen et al., INCREASE IN AP-1 TRANSCRIPTION FACTOR DNA-BINDING ACTIVITY BY VALPROIC ACID, Neuropsychopharmacology, 16(3), 1997, pp. 238-245

Authors: SCHMIDT ME RISINGER RC HAUGER RL SCHOUTEN JL HENRY M POTTER WZ
Citation: Me. Schmidt et al., RESPONSES TO ALPHA(2)-ADRENOCEPTOR BLOCKADE BY IDAZOXAN IN HEALTHY MALE AND FEMALE VOLUNTEERS, Psychoneuroendocrinology, 22(3), 1997, pp. 177-188

Authors: DEMITRACK MA FARIES D DEBROTA D POTTER WZ
Citation: Ma. Demitrack et al., THE PROBLEM OF MEASUREMENT ERROR IN MULTISITE CLINICAL-TRIALS, Psychopharmacology bulletin, 33(3), 1997, pp. 513-513

Authors: SCHMIDT ME GOLDSTEIN DS SCHOUTEN JL MATOCHIK JA KIM HG POTTER WZ
Citation: Me. Schmidt et al., ACUTE ALPHA(2) BLOCKADE BY IDAZOXAN INCREASES INSULIN AND LOWERS PLASMA-GLUCOSE DURING POSITRON EMISSION TOMOGRAPHY, Psychopharmacology bulletin, 33(2), 1997, pp. 253-259

Authors: BODICK NC OFFEN WW LEVEY AI CUTLER NR GAUTHIER SG SATLIN A SHANNON HE TOLLEFSON GD RASMUSSEN K BYMASTER FP HURLEY DJ POTTER WZ PAUL SM
Citation: Nc. Bodick et al., EFFECTS OF XANOMELINE, A SELECTIVE MUSCARINIC RECEPTOR AGONIST, ON COGNITIVE FUNCTION AND BEHAVIORAL SYMPTOMS IN ALZHEIMER-DISEASE, Archives of neurology, 54(4), 1997, pp. 465-473

Authors: MITCHELL PB MANJI HK CHEN G JOLKOVSKY L SMITHJACKSON E DENICOFF K SCHMIDT M POTTER WZ
Citation: Pb. Mitchell et al., HIGH-LEVELS OF G(S)ALPHA IN PLATELETS OF EUTHYMIC PATIENTS WITH BIOPOLAR AFFECTIVE-DISORDER, The American journal of psychiatry, 154(2), 1997, pp. 218-223

Authors: JACOBSEN LK FRAZIER JA MALHOTRA AK KAROUM F MCKENNA K GORDON CT HAMBURGER SD LENANE MC PICKAR D POTTER WZ RAPOPORT JL
Citation: Lk. Jacobsen et al., CEREBROSPINAL-FLUID MONOAMINE METABOLITES IN CHILDHOOD-ONSET SCHIZOPHRENIA, The American journal of psychiatry, 154(1), 1997, pp. 69-74

Authors: MANJI HK BERSUDSKY Y CHEN G BELMAKER RH POTTER WZ
Citation: Hk. Manji et al., MODULATION OF PROTEIN-KINASE-C ISOZYMES AND SUBSTRATES BY LITHIUM - THE ROLE OF MYOINOSITOL, Neuropsychopharmacology, 15(4), 1996, pp. 370-381

Authors: CHEN G MANJI HK WRIGHT CB HAWVER DB POTTER WZ
Citation: G. Chen et al., EFFECTS OF VALPROIC ACID ON BETA-ADRENERGIC RECEPTORS, G-PROTEINS, AND ADENYLYL-CYCLASE IN RAT C6 GLIOMA-CELLS, Neuropsychopharmacology, 15(3), 1996, pp. 271-280

Authors: STEIN MB CHEN G POTTER WZ MANJI HK
Citation: Mb. Stein et al., G-PROTEIN LEVEL QUANTIFICATION IN PLATELETS AND LEUKOCYTES FROM PATIENTS WITH PANIC DISORDER, Neuropsychopharmacology, 15(2), 1996, pp. 180-186

Authors: CASTELLANOS FX ELIA J KRUESI MJP MARSH WL GULOTTA CS POTTER WZ RITCHIE GF HAMBURGER SD RAPOPORT JL
Citation: Fx. Castellanos et al., CEREBROSPINAL-FLUID HOMOVANILLIC-ACID PREDICTS BEHAVIORAL-RESPONSE TOSTIMULANTS IN 45 BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER, Neuropsychopharmacology, 14(2), 1996, pp. 125-137

Authors: POTTER WZ
Citation: Wz. Potter, KEY ISSUES IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER, Journal of clinical psychopharmacology, 16(2), 1996, pp. 1-3

Authors: POTTER WZ
Citation: Wz. Potter, KEY ISSUES IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER, Journal of clinical psychopharmacology, 16(2), 1996, pp. 1-1

Authors: SCHMIDT ME ERNST M MATOCHIK JA MAISOG JM PAN BS ZAMETKIN AJ POTTER WZ
Citation: Me. Schmidt et al., CEREBRAL GLUCOSE-METABOLISM DURING PHARMACOLOGICAL STUDIES - TEST-RETEST UNDER PLACEBO CONDITIONS, The Journal of nuclear medicine, 37(7), 1996, pp. 1142-1149

Authors: POTTER WZ
Citation: Wz. Potter, ADRENOCEPTORS AND SEROTONIN RECEPTOR FUNCTION - RELEVANCE TO ANTIDEPRESSANT MECHANISMS OF ACTION, The Journal of clinical psychiatry, 57, 1996, pp. 4-8

Authors: MANJI HK CHEN G HSIAO JK RISBY ED MASANA MI POTTER WZ
Citation: Hk. Manji et al., REGULATION OF SIGNAL-TRANSDUCTION PATHWAYS BY MOOD-STABILIZING AGENTS- IMPLICATIONS FOR THE DELAYED-ONSET OF THERAPEUTIC EFFICACY, The Journal of clinical psychiatry, 57, 1996, pp. 34-48

Authors: CHEN G PAN BS HAWVER DB WRIGHT CB POTTER WZ MANJI HK
Citation: G. Chen et al., ATTENUATION OF CYCLIC-AMP PRODUCTION BY CARBAMAZEPINE, Journal of neurochemistry, 67(5), 1996, pp. 2079-2086

Authors: LITMAN RE SU TP POTTER WZ HONG WW PICKAR D
Citation: Re. Litman et al., IDAZOXAN AND RESPONSE TO TYPICAL NEUROLEPTICS IN TREATMENT-RESISTANT SCHIZOPHRENIA - COMPARISON WITH THE ATYPICAL NEUROLEPTIC, CLOZAPINE, British Journal of Psychiatry, 168(5), 1996, pp. 571-579
Risultati: 1-25 | 26-50 | 51-59